YB-169, A BRACHYTHERAPY SOURCE - PRELIMINARY-REPORT ON A PHASE I-II STUDY

被引：0
|
作者：
MONTEMAGGI, P
PIERMATTEI, A
SMANIOTTO, D
LUZI, S
ZICCARELLI, L
CELLINI, N
机构：
来源：
RADIOLOGY | 1995年 / 197卷
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
引用
收藏
页码：188 / 188
页数：1
相关论文
共 50 条
  • [1] YB-169 - EXPERIMENTAL EVALUATION OF A NEW BRACHYTHERAPY SOURCE
    MIELER, WF
    MURRAY, TG
    BOLDT, HC
    ZELLMER, D
    ERICKSON, B
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 1991, 32 (04) : 979 - 979
  • [2] YB-169 - CALCULATED PHYSICAL-PROPERTIES OF A NEW RADIATION SOURCE FOR BRACHYTHERAPY
    MASON, DLD
    BATTISTA, JJ
    BARNETT, RB
    PORTER, AT
    MEDICAL PHYSICS, 1992, 19 (03) : 695 - 703
  • [3] Monte Carlo characterization of a new Yb-169 high dose rate source for brachytherapy application
    Cazeca, Mario J.
    Medich, David C.
    Munro, John J., III
    MEDICAL PHYSICS, 2010, 37 (03) : 1129 - 1136
  • [4] Enabling Rotating Shield Brachytherapy with Efficient Yb-169 High-Dose-Rate Brachytherapy Source Production by Re-Activation
    Flynn, R.
    Adams, Q.
    Hopfensperger, K.
    Wu, X.
    Xu, W.
    Kim, Y.
    MEDICAL PHYSICS, 2019, 46 (06) : E114 - E114
  • [5] Dynamic-Direction Modulated Brachytherapy (d-Dmbt) For Cervical Cancer Using HDR Yb-169 Source
    Safigholi, H.
    Song, W.
    MEDICAL PHYSICS, 2018, 45 (06) : E173 - E173
  • [6] The Sievert integral revisited: Evaluation and extension to I-125, Yb-169, and Ir-192 brachytherapy sources
    Williamson, JF
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1996, 36 (05): : 1239 - 1250
  • [7] Interstitial high dose rate brachytherapy for partial breast irradiation: Preliminary results of a phase I-II prospective study
    Palumbo, I.
    Corazzi, F.
    Raymondi, C.
    Tarducci, R.
    Cavalli, A.
    Rulli, A.
    Cavaliere, A.
    Aristei, C.
    RADIOTHERAPY AND ONCOLOGY, 2006, 81 : S263 - S263
  • [8] First report of an institutional phase I-II trial of perioperative fractionated HDR brachytherapy (PHDRB)
    Martínez-Monge, R
    Cambeiro, M
    Garrán, C
    Jurado, M
    Alcaide, J
    San Julián, M
    Amillo, S
    Concejo, C
    Hernández-Lizoain, J
    Pardo, F
    RADIOTHERAPY AND ONCOLOGY, 2004, 71 : S60 - S61
  • [9] Phase I-II study with epidoxorubicin (EDX) and gemcitabine (GEM) in stage IVNSCLC. Preliminary report
    Illiano, A
    Tortoriello, A
    Turitto, G
    Facchini, G
    Battiloro, C
    Frattolillo, A
    De Marino, V
    Libutti, M
    Perone, V
    Griffo, S
    Elia, S
    Gentile, M
    Iaffaioli, RV
    ANNALS OF ONCOLOGY, 2000, 11 : 5 - 5
  • [10] INTRAVESICAL THERAPY OF SUPERFICIAL BLADDER TRANSITIONAL CELL-CARCINOMA WITH TUMOR-NECROSIS-FACTOR-ALPHA - PRELIMINARY-REPORT OF A PHASE I-II STUDY
    SERRETTA, V
    CORSELLI, G
    PIAZZA, B
    FRANKS, CR
    PALMER, PA
    ROEST, GJ
    PAVONEMACALUSO, M
    EUROPEAN UROLOGY, 1992, 22 (02) : 112 - 114
12345